Projects per year
Projects
- 46 Finished
Search results
-
Finished
ISSF 12/13 - Urinary methylation markers for bladder cancer surveillance - the utility of N.G.S.
Ward, D., Bryan, R., James, N., Matthews, G. & Wei, W.
1/03/13 → 30/11/14
Project: Research
-
Molecular Markers for non muscle invasive bladder cancer
James, N., Bryan, R., Deshmukh, N., Zeegers, M., Murray, P., Riley, R. & Cheng, K.
30/07/12 → 29/04/17
Project: Research
-
MRE11 as an Outcome Prediction Biomarker in Bladder Cancer Radiotherapy (MOBIBLART) - CRUK via Oxford
1/03/12 → 28/02/15
Project: Research
-
Detection of Gene Fusions Suitable as Biomarkers for Invasive and Non-Invasive Bladder Cancer using Transcriptome Sequencing on Two High-Throughput Platforms
James, N., Pallen, M., Badenhorst, P., Arrand, J. & Bryan, R.
14/06/11 → 30/06/12
Project: Research
-
(24MTHS)Phase I/II Feasibility Study of Cetuximab With or Without Cisplatin With Concurrent Radiotherapy in Muscle Invasive Bladder Cancer
James, N. & Hussain, S.
1/02/10 → 30/06/16
Project: Research
-
(60MTHS)CRUK Clinical Trials Unit, University of Birmingham
Kearns, P., Billingham, L., Bowden, S., Craddock, C., Doran, J., James, N., Moss, P., Palmer, D., Porfiri, E., Rea, D. & Steven, N.
1/10/08 → 30/09/13
Project: Research
-
(Joint with 13512) A Randomised Phase III Study of Docetaxel plus Prednisolone vs Docetaxel with Prednisolone plus Either Zoledronic Acid, Strontium-89 or Both Agents Combined
James, N., Porfiri, E., Barton, P. & Billingham, L.
NIHR EVALUATION, TRIALS AND STUDIES COORDINATING CENTRE
1/04/07 → 31/05/18
Project: Research
-
(Joint with 13006) A Randomised Phase III Study of Docetaxel plus Prednisolone vs Docetaxel with Prednisolone plus Either Zoledronic Acid, Strontium-89 or Both Agents Combined
James, N., Porfiri, E., Billingham, L. & Yao, G.
NIHR EVALUATION, TRIALS AND STUDIES COORDINATING CENTRE
1/04/07 → 28/02/13
Project: Other Government Departments
-
A Study of Ad-NTR-GMCSF, Given via Brachytherapy, Followed by CB1954 in Patients with Locally Relapsed Prostate Cancer
Porfiri, E., James, N., Mautner, V., Searle, P., Lee, S. & Young, L.
Medical Research Council, NIHR
19/03/07 → 18/07/15
Project: Research
-
Prodrug Activation Gene Therapy for Cancer: Optimising Enzymes, Vectors and Immune Responses
Searle, P., James, N., Mautner, V., Palmer, D., Porfiri, E. & Young, L.
1/12/06 → 31/10/09
Project: Research
-
(linked to RHCZ12294)A SU011248 Expanded Access Protocol for Systematic Therapy of Patients with Metastatic Renal Cell Carcinoma who are Eligible for Participation in Other SU011248 Protocols and may Derive Benefit from Treatment with SU...
Queen Elizabeth Hospital Birmingham
1/07/06 → 31/12/14
Project: Research
-
Pzifer - A SU011248 Expanded Access Protocol for Systematic Therapy of Patients with Metastatic Renal Cell Carcimona who are Eligible for Participation in Other SU011248 Protocols and may Derive Benefit from Treatment with SU011248.
Queen Elizabeth Hospital Birmingham
1/07/06 → 31/12/12
Project: Research
-
Recurrence and Progression of Non-Muscle-Invasive Bladder Cancer
Cheng, K., Zeegers, M., James, N., Billingham, L., Hussain, S. & Murray, P.
Cancer Research UK, DUDLEY GROUP OF HOSPITALS, NIHR
1/05/05 → 31/08/11
Project: Research
-
A Phase II, Randomised, Double-Blind, Parallel-Group, Placebo-Controlled, Multi-Centre Study To Assess the Activity Of Once-Daily Orally Administered ZD4054 15MG and 10MG Doses On Bone Metastases In Pain-Free Or Mildly Systematic Patients..
Queen Elizabeth Hospital Birmingham
1/01/05 → 31/12/07
Project: Research
-
A Randomised Phase II Feasibility Study of Docetaxel plus Prednisolone vs Docetaxel plus Prednisolone plus Zoledronic acid vs docetaxel plus Prednisolone plus Strontium-89 vs Docetaxel plus prednisolone plus Zoledronic acid plus Strontium-8
AVENTIS PHARMA LTD, NOVARTIS PHARMACEUTICALS UK LTD
1/12/04 → 31/07/14
Project: Research
-
-
A Phase III Extension Study To Evaluate The Safety Of 10mg Atrasentan In Men With Hormone-Refractory Prostate Cancer.
1/01/02 → 31/12/05
Project: Industry
-
A Randomised Controlled Trial Of Interferon, Interleukin-2 and 5-fluroruracil renal cell carcinoma
1/11/01 → 31/12/04
Project: Research Councils
-
Gene Therapy Prostate Cancer Study ( CTC99010)
COBRA THERAPEUTICS LTD, ML LABORATORIES LIMITED, Queen Elizabeth Hospital Birmingham, INNOVATA PLC
1/10/01 → 30/04/08
Project: Research
-
-
Stealth Adenovirus targeted to the Epidermal Growth Factor Receptor and HER2 for Treatment of Peritoneal Carcinomatoses
Seymour, L., Mautner, V. & James, N.
1/10/00 → 30/09/02
Project: Research Councils
-
Preclinical Studies of Virus Directed Enzyme Prodrug Therapy (VDEPT) in Prostate Cancer
Young, J. & James, N.
1/04/00 → 31/03/03
Project: Research
-
-
Development of Gamma Ray Holography for Medical Imaging
Beynon, D., James, N. & Cruickshank, G.
Engineering & Physical Science Research Council
1/05/99 → 31/01/03
Project: Research Councils
-
The Development Of The Website 'CancerHelp UK'
James, N. & Tweddle, S.
1/01/98 → 31/07/00
Project: Industry
-
-
Research & Development for a Boron Cancer Therapy Clinical Facility
Beynon, D., James, N. & Kerr, D.
3/12/96 → 31/03/98
Project: Other Government Departments
-
Improved Access To UK Based Cancer Information Through TheInternet For Patients Carers And Health Care Professionals.
James, N. & Tweddle, S.
1/10/96 → 31/12/97
Project: Research
-
Isolation Of Single-Chain Antibody Reagents Specific ForCTLA-4 And Use In Generating Tumour-Specific CTL.
Searle, P. & James, N.
1/10/96 → 30/09/98
Project: Research Councils
-
A Phase II Study To Determine The Biological Effects OfBispecific Antibody MDX H210 (520c9xh22).
1/08/96 → 31/12/00
Project: Research
-
Research & Development Project On The Dissemination OfInformation About Cancer Via The Internet.
Tweddle, S. & James, N.
1/05/96 → 30/04/97
Project: Research
-
Trial Recruitment in the West Midlands Region
PROSTRATE CANCER CURE FOUNDATION
1/01/95 → 31/12/95
Project: Research